The title compound C6N7(NHNH2)3 (1) was obtained from melem C6N7(NH2)3 or melon [C6N7(NH2)NH]n and hydrazine by an autoclave synthesis. Upon treatment with a 10 % HCl solution it is transformed into the trihydrochloride [C6N7(NHNH3)3]Cl3 (2). Compounds 1 and 2 were analysed with 13C NMR, 15N NMR, FTIR and Raman spectroscopy. Furthermore, the single‐crystal X‐ray structure of the pentahydrate of 2 is reported (P1̄, a = 674.96(3), b = 1214.17(6), c = 1272.15(6) pm, α = 66.288(2)°, β = 75.153(2)°, γ = 80.420(2)°, V = 920.30(8)·106 pm3, Z = 2, T = 90(2) K). The thermal decomposition of 1 and 2 was investigated with TG/DTA. Reaction of 1 with NaNO2/HCl yields triazido‐s‐heptazine, C6N7(N3)3 (3). Tris(tri‐n‐butylphosphinimino)‐s‐heptazine (4) was synthesised from 3 and characterised by means of 13C, 31P, 1H NMR, FTIR and MALDI‐TOF spectroscopy. Similar to s‐heptazine derivative 3, compounds 1 and 4 are precursors for graphitic carbon nitrides, which have attracted considerable attention recently, and to various potential applications, such as flame retardants and (photo) catalysis.
No takes yet. Share an insight, caveat, or question.
Saplinova et al. (2009) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: